NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth ... (ffectively than current treatments witho...)

NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference

Date:3/19/2013

ffectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. The Company has a broad platform technology for DCVax^® dendritic cell-based vaccines. The Company's lead program is a 312-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal brain cancer. The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I/II trials in multiple other cancers. The Company has also conducted a Phase I/II trial with DCVax^® for metastatic ovarian cancer together with the University of Pennsylvania.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax^® and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patients in its clinical trials and complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy. Additional information on these and other factors, including Ri
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
2. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
3. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
4. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
5. Nonprofit Consortium Publishes Review of Skullcap Adulteration
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
8. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
9. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
10. Alzheimers Therapeutics Reviewed by NeuroPerspective
11. Peer Reviewed Clinical Study Shows New Blood Test More Accurately Predicts Risk Of A Heart Attack

Post Your Comments:

(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...

(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...

(Date:5/23/2013)... , May 23, 2013 Z Trim Holdings, ... ingredients to a variety of industries, announced that Chef ... panel discussion at this year,s National Restaurant Association ("NRA") ... on behalf of the Research Chefs Association. Chef Ryan ... The Good, the Bad and the Ugly," joining four ...

(Date:5/23/2013)... Canada (PRWEB) May 23, 2013 ... it is critical to adhere to principles of ... (HSP). , Esteemed speaker Dr. Jeremy Lim, Fellow, ... audience: , , Understand the International ... Practice (GCP) and additional regulations for the conduction ...

Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2 VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2 VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3 Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2 Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3 Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2

[0] Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing”[0] VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials [0] Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show [0] Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks

... Olive stones can be turned into bioethanol, a renewable fuel ... an alternative to petrol or diesel. This gives the olive ... million tonnes of waste in olive stones it generates every ... products as fuels. Researchers from the Universities of Jan and ...

... MNKD ) will release its 2008 third quarter financial,results ... Management of the Company will host a conference ... and other Company,developments at 9:00 a.m. EST on November ... and Chief Executive Officer, Alfred Mann;,President and Chief Operating ...

... - Non-GAAP Operating Earnings Up 27%, GAAP Operating Earnings Up ... Non-GAAP Diluted EPS Up 29%, GAAP Diluted EPS Up 32%, ... today reported fourth fiscal quarter 2008 revenues of,$282.5 million, representing ... fourth quarter of fiscal year 2007, with strong orders and,excellent ...

Powered by olive stones? Turning waste stones into fuel MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008 Varian, Inc. Reports Strong Fourth Quarter 2008 Results

(Date:5/23/2013)... most popular fruit, can be made both better-tasting and ... , "Working with GM tomatoes that are different ... specific compound, allows us to pinpoint exactly how to ... the John Innes Centre. , The research could also ... shelf life characteristics because even higher levels of the ...

(Date:5/23/2013)... nucleosomes in the cell nucleus makes it unavailable ... in Munich now describes a mechanism that allows ... for transcription. , In higher organisms the genomic ... around disk-shaped particles called nucleosomes, each consisting of ... accommodating two loops of DNA. Packed in this ...

(Date:5/23/2013)... the world are billions of animal and plant specimens ... grasses, all stacked, stored and preserved in jars and ... be critical to understanding how the Earth,s biodiversity is ... if only the information were easily accessible. , ... help of a team from the University of Colorado ...

Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2 Biochemistry: Unspooling DNA from nucleosomal disks 2 CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2 CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3 CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4

[0] The world's favorite fruit only better-tasting and longer-lasting [0] Biochemistry: Unspooling DNA from nucleosomal disks [0] CU-Boulder helps tap crowds to digitize museum records of bugs and plants

... International, Inc.,(OTC Bulletin Board: BKYI) today announced plans to release ... the market opens.,In conjunction with the release, BIO-key has scheduled ... on Thursday, May 15, 2008 at,9:00 a.m. Eastern Time., ... Earnings Conference ...

... is more important for predicting biodiversity than biology",Research published ... challenges current thinking about biodiversity and opens up new ... may affect biodiversity patterns. In the article, ... of fish species in a river system can be ...

... the genome sequence of the duck-billed platypus was published ... about how genomes were organized during the early evolution ... the National Human Genome Research Institute (NHGRI), part of ... TV nature shows will remember that the duck-billed platypus, ...

Cached Biology News:BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2 Biodiversity -- it's in the water 2 Duck-billed platypus genome sequence published 2 Duck-billed platypus genome sequence published 3 Duck-billed platypus genome sequence published 4

BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule Biodiversity -- it's in the water Duck-billed platypus genome sequence published

Request Info...

HIF-1 beta (ARNT1) Purified Anti-Mouse, Anti-Rat, Anti-Human clone 29, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....

Anti-TWIK-1 Immunogen: Purified peptide from amino acids 53-69 of human TWIK-1 (Accession number O00180)....

Biology Products:

RayBio Human Matrix Metalloproteinase Antibody Array I & 1.1 Service from Raybiotech, Inc.RayBio Mouse Atherosclerosis Antibody Array I & 1.1 Service from Raybiotech, Inc.Mouse Anti-HIF-1 beta Monoclonal Antibody, Unconjugated, Clone 29 from BD Biosciences Pharmingen Rabbit Anti-TWIK-1 Antibody, Unconjugated from CHEMICON